 It all started in 2012. It was a joint initiative by the Lisbon University Institute and EMCDDA. The university could offer an international programme to credits. EMCDDA could participate with the contents. We get support from NIDA and we started. The objective of the summer school is to provide professionals and academics with the opportunity to learn from the EMCDDA staff members and international keynote speakers about drug policies and practices. Come here to look at what other people are doing, to get an insider's view about European drug policy making. We have about 50 hours didactic, including workshops held by the students, interactive lessons and we have visits to, for example, outreach units and treatment centres that are very appreciated by the students. Really a very interesting school, two weeks with people really specialised in the topic and very enthusiastic about the topic. We had more than 200 students over the last six years. We had experience from the ground, professional working with drug addicts in the street or people in the commission or people doing research. Because of the high profile of our students, it is very lively, there is a lot of participation. I think one of the added value of the summer school is that students really came from very different backgrounds and geographical contexts. So for example in some of the countries the debate on the legalisation of some drugs is more advanced while in the other there is still discussion about the access to treatment and we had this amazing opportunity to bring these people discussing together. It has been a quite informative and enlightening training experience that I believe should not be perceived as limited to people living or working within the European Union. Now that I have taken part I think anyone from any part of the world can participate in this training programme as the information and experience shared are quite transferable between different settings in the world. We decided to organise the programme around themes. In 2017 we will talk about strategies and policies to reduce effectively drug-related mortality. Any researchers, anyone who would like to update themselves about the current issues around the European Union, definitely I would recommend them to come down. Besides that, it's good networking. You get to meet some lovely people and it's really nice.